The financing includes new investors Pfizer Ventures and Apricot Capital, bringing the total capital raised to $100m ...

For decades, pharma communications spoke the language of health systems, designed to inform healthcare professionals, ...

Vibrant Therapeutics, a clinical-stage biotechnology company specialising in intelligent therapeutics, has appointed Han Lee ...

Learn how a next-generation approach to field training – powered by Generative AI (GenAI) and lifelike avatar simulations and ...

Takeda’s zasocitinib has shown strong rates of skin clearance, as well as other benefits, in new study results regarding ...

NanoSyrinx has announced the appointment of Thomas J Farrell as its new CEO.

The terms of the agreement state that AbbVie will provide lower-priced prescription drugs through the Medicaid programme. It ...

Novo Nordisk’s Wegovy (semaglutide injection) has received a new approval from the Medicines and Healthcare products ...

Colorectal cancer is the third most common cancer globally, with approximately 1.8 million people diagnosed in 2022 ...

Eli Lilly has announced that it has entered into a definitive agreement to acquire Ventyx Biosciences, a biopharmaceutical ...

Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, ...

Bristol Myers Squibb (BMS) has agreed as part of a deal with the US government to provide Eliquis (apixaban) free of charge ...